Enovix (ENVX) Operating Expenses (2020 - 2026)

Enovix has reported Operating Expenses for 7 years, with the latest figure at $45.4 million in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 6.13% year-over-year to $45.4 million; the trailing twelve-month figure through Apr 2026 stood at $186.0 million (down 13.54% YoY), and the FY2025 full-year result was $183.4 million, down 23.8% from the prior year.
• Operating Expenses for Q2 2026 stood at $45.4 million, down from $46.5 million in the prior quarter.
• The five-year high for Operating Expenses was $88.1 million in Q2 2024, with the low at $24.6 million in Q2 2022.
• Historically, Operating Expenses has averaged $46.8 million across 5 years, with a median of $45.7 million in 2025.
• Annual changes were most pronounced in 2022 — Operating Expenses soared 1408.28% — and 2025, when it slumped 48.15%.
• Enovix's Operating Expenses stood at $27.1 million in 2022, then jumped by 93.62% to $52.4 million in 2023, then sank by 32.11% to $35.6 million in 2024, then surged by 30.7% to $46.5 million in 2025, then dropped by 2.24% to $45.4 million in 2026.
• The last three Operating Expenses figures came in at $45.4 million (Q2 2026), $46.5 million (Q4 2025), and $48.4 million (Q3 2025), per Business Quant data.